9 Dublin biotech investors write €25K-€5M for Irish life science startups in 2026. Frontline Ventures, Delta Partners, and Kernel Capital close in 6-16 weeks. Ireland's biotech raised €220M in 2025.
Ireland's biotech market raised €220M in 2025, up 28% from 2024. Dublin captures 78% of Irish biotech VC as Europe's second pharma cluster per capita.
Frontline and Delta closed €55M in Dublin biotech seed deals in 2025. Irish biotech with Trinity RCSI affiliation and SFI grant closes Dublin VCs fastest.
Pfizer, Johnson & Johnson, and Novo Nordisk Dublin bases anchor the cluster. Irish biotech with Pfizer or Novo Nordisk pilot agreement closes Atlantic Bridge fastest.
This guide covers 9 active biotech investors in Dublin writing cheques in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| Frontline Ventures | Seed / Series A VC | €500K-€5M | Irish biotech, life sciences, seed | frontline.vc |
| Delta Partners | Seed / Series A VC | €500K-€5M | Irish biotech, pharma, deep tech | delta.partners |
| Atlantic Bridge | Growth / Series A VC | €1M-€10M | Irish biotech, pharma, Series A | abven.com |
| Enterprise Ireland | Public seed VC | €50K-€500K | Irish biotech HPSU public fund | enterprise-ireland.com |
| HBAN Business Angels | Angel network | €25K-€500K | Irish biotech, life sci, angel | hban.com |
| Kernel Capital | Seed / Series A VC | €500K-€5M | Irish biotech, life sciences | kernelcapital.ie |
| Science Foundation Ireland | Grant / VC hybrid | €100K-€2M | Irish biotech research grant | sfi.ie |
| NCT Ventures | Seed / Series A VC | €200K-€3M | Irish biotech, pharma, health AI | nctventures.com |
| Modus Capital | Seed / Series A VC | €200K-€3M | Irish biotech, life sciences, B2B | moduscapital.eu |
Dublin biotech VCs require NDA before IP and clinical pipeline review. Ellty logs every investor who opens your materials.
Start free 14-day trialDublin biotech VCs require RCSI or Trinity affiliation and SFI grant before seed. Irish biotech with Trinity spin-out status closes Frontline and Delta 6 weeks faster.
EMA preclinical data and IP patent filing close Dublin biotech VCs fastest. Irish biotech with granted patent and EMA preclinical data closes seed in 8 weeks.
Share your Dublin biotech pitch via virtual data room with timed investor access. Dublin biotech VCs open IP, preclinical, and cap table within 48 hours of link.
Enterprise Ireland backs pre-revenue biotech with HPSU innovation grants. Enterprise Ireland HPSU biotech grant recipient closes all Dublin VCs 5 weeks faster.
Dublin biotech closes fastest when founders hold Trinity or RCSI spin-out status, SFI grant, and EMA preclinical package. That stack cuts 6 weeks from every Dublin biotech term sheet.
Frontline Ventures is Dublin's most active transatlantic seed fund, backing B2B and life science startups at €500K–€5M with a direct bridge to the US market.
Recent Deals: Realm €2M seed 2025, Seapoint €1.5M seed 2025, 10 new investments in last 12 months
LinkedIn: Frontline Ventures LinkedIn
Sector Focus: Biotech, Life Sciences, B2B SaaS, Enterprise Tech
Stage Focus: Seed, Series A
Location: Dublin, Ireland
Website: frontline.vc
Delta Partners is a Dublin-based early-stage VC with a €70M fund backing Irish biotech, pharma tech, and deep tech at seed through Series A.
Recent Deals: Imvizar Series A 2024, VisionR seed 2024, 30+ portfolio companies across life sciences
LinkedIn: Delta Partners LinkedIn
Sector Focus: Biotech, Pharma Tech, Deep Tech, Life Sciences
Stage Focus: Seed, Series A
Location: Dublin, Ireland
Website: deltapartners.com
Atlantic Bridge is Dublin's leading growth equity firm managing €400M+ across European and US deep tech and biotech, with offices in Dublin, London, Munich, Paris, and Palo Alto.
Recent Deals: Neurotech company participation €8M Series A 2026, quantum startup participation 2025, 8 investments in last 12 months
LinkedIn: Atlantic Bridge LinkedIn
Sector Focus: Biotech, Pharma, Life Sciences, Deep Tech
Stage Focus: Series A, Growth
Location: Dublin, Ireland
Website: abven.com
Enterprise Ireland is Ireland's state agency deploying €32.9M annually into 198 startups, with HPSU equity up to €1.2M and pre-seed grants of €50K–€100K for Irish biotech.
Recent Deals: 90 HPSU companies €23M equity 2025, 108 pre-seed companies €9.55M 2025, supports Irish biotech with EMA-track funding
LinkedIn: Enterprise Ireland LinkedIn
Sector Focus: Biotech, Life Sciences, Pharma, HPSU Startups
Stage Focus: Pre-Seed, Seed
Location: Dublin, Ireland
Website: enterprise-ireland.com
HBAN, voted Europe's best-performing angel network in 2025, connects 400+ angels deploying €12M+ per year into Irish biotech, medtech, and life science startups.
Recent Deals: CroiValve medtech 2024, OncoAssure biotech 2024, Neurobell seed 2024, €14.9M via Medtech Syndicate 2023–2024
LinkedIn: HBAN LinkedIn
Sector Focus: Biotech, Medtech, Life Sciences, SaaS
Stage Focus: Angel, Pre-Seed, Seed
Location: Dublin, Ireland
Website: hban.com
Ellty shows when Frontline or Delta opens your preclinical data and patent docs. Follow up now.
Start free 14-day trialKernel Capital manages the Bank of Ireland Kernel Capital Venture Funds, one of Ireland's largest equity sources for technology and biotech companies, with offices in Dublin, Cork, and Belfast.
Recent Deals: BioAtlantis €750K biotech 2024, Cirdan £2.3M digital pathology 2024, Pretto Series C October 2024
LinkedIn: Kernel Capital LinkedIn
Sector Focus: Biotech, MedTech, Life Sciences, Technology
Stage Focus: Seed, Series A
Location: Dublin, Ireland (also Cork & Belfast)
Website: kernelcapital.ie
Science Foundation Ireland funds €250M+ annually in Irish biotech and pharma research, backing spin-outs from Trinity, UCD, and RCSI with commercialisation grants up to €2M.
Recent Deals: Multiple Trinity and UCD spin-out research grants 2025, Aerska RNA biotech ecosystem support 2025–2026
LinkedIn: Science Foundation Ireland LinkedIn
Sector Focus: Biotech, Pharma, Life Sciences Research
Stage Focus: Research Grant, Pre-Seed
Location: Dublin, Ireland
Website: sfi.ie
NCT Ventures backs Irish biotech, diagnostics, and health AI at €200K–€3M seed stage, with a focus on startups with hospital validation and SFI research backing.
Recent Deals: Irish diagnostics startup seed €500K 2024, health AI platform €1M 2024, 20+ investments in Irish biotech and life sciences
LinkedIn: NCT Ventures LinkedIn
Sector Focus: Biotech, Diagnostics, Health AI, Life Sciences
Stage Focus: Seed, Series A
Location: Dublin, Ireland
Website: nctventures.com
Modus Capital backs Irish biotech and life science B2B companies at €200K–€3M seed stage, focusing on startups with HPSU accreditation and European expansion plans.
Recent Deals: Irish biotech B2B seed €500K 2024, life sciences platform €750K 2024, 15+ portfolio companies across Irish biotech
LinkedIn: Modus Capital LinkedIn
Sector Focus: Biotech, Life Sciences, B2B Health
Stage Focus: Seed, Series A
Location: Dublin, Ireland
Website: moduscapital.eu
Ireland hosts 9 of the top 10 global pharma companies at full manufacturing scale. Dublin biotech with Pfizer or Janssen manufacturing pilot closes Atlantic Bridge fastest.
IDA Ireland backs biotech with €50K-€500K facility and talent grants. IDA Ireland biotech grant recipient closes Enterprise Ireland and SFI 4 weeks faster.
Build your Dublin biotech VC pitch via document tracking software. Dublin biotech VCs open IP, preclinical, and pipeline docs within 24 hours.
Horizon Europe Innovative Health Initiative funds €1.5B in EU biotech in 2026. Horizon Europe IHI consortium closes Delta and SFI 5 weeks faster than cold.
EMA preclinical package takes 18-24 months for Irish biotech Drug Discovery. Irish biotech with EMA preclinical data closes Kernel and Frontline 6 weeks faster.
EPO patent filing costs €15K-€40K and grants priority date for Dublin biotech. Irish biotech with granted EPO patent closes Dublin VCs 5 weeks faster than provisional.
Review patent strategy via NDA template and IP disclosure before Dublin VC meetings. Dublin biotech VCs open IP and patent before reviewing financial projections.
Pfizer and Novo Nordisk Dublin open CRADAs for Irish biotech innovation in 2026. Pfizer Ireland CRADA agreement closes Atlantic Bridge Series A 6 weeks faster.
Trinity College Dublin generates 12+ biotech spin-outs per year in 2026. RCSI Dublin produces 8+ biotech spin-outs per year with SFI commercialisation grants.
Trinity ADAPT Centre and RCSI SurgBio lab accelerate biotech IP into spinouts. ADAPT or SurgBio affiliation closes Frontline and Delta same week as application.
Track your Dublin biotech VC pipeline via pitch deck builder and deck tracking. Dublin biotech VCs open IP and EMA preclinical deck before term sheet discussion.
Bioatlantech cluster connects Galway and Dublin biotech with EU pharma partners. Bioatlantech member closes Enterprise Ireland and IDA Ireland 4 weeks faster.
Lead with RCSI spin-out, SFI grant, and EMA preclinical.
Ellty is a data room for biotech founders. Know when Frontline or Kernel opens your IP and preclinical docs.


